<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-148806</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Inflammatory myofibroblastic tumor and intussusception: an unusual presentation</dc:title>
<dc:description xml:lang="en">Inflammatory myofibroblastic tumors (IMTs) are a group of rare neoplastic lesions that occur in children and young adults. Their most frequent locations are lungs and the abdominal region, being abdominal pain or palpable mass the most common symptoms. Bowel intussusception is very unusual. We present a 5-years-old boy with abdominal pain and inflammatory signs, with an intramural ileal IMT presenting with intussusception. The treatment of choice is a complete, nonmutilating excision, and close follow-up are necessary because of their high rate of recurrences (AU)</dc:description>
<dc:creator>Pérez Aragón, C</dc:creator>
<dc:creator>Rubio Santiago, J</dc:creator>
<dc:creator>Atienza Cuevas, L</dc:creator>
<dc:creator>Quirós Espigares, N</dc:creator>
<dc:creator>Mayordomo Morales, I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los tumores miofibroblásticos inflamatorios (TMI) son un grupo infrecuente de neoplasias que afectan predominantemente a niños y adultos jóvenes. Se localizan habitualmente en pulmones y cavidad abdominal, donde se manifiestan en forma de masa palpable y dolor abdominal, siendo la invaginación intestinal excepcional. Presentamos el caso clínico de un niño de 5 años con dolor abdominal y síndrome constitucional, que en las pruebas de imagen presenta invaginación yeyuno-yeyunal de probable causa orgánica. Tras la exéresis quirúrgica se identificó por histología un TMI. Aunque el pronóstico de este tumor es bueno, siempre que se consiga la exéresis completa, el seguimiento de estos pacientes es obligado, dada la alta tasa de recurrencia (AU)</dc:description>
<dc:source>Acta Pediatr Esp;74(1): e1-e6, ene. 2016. ilus</dc:source>
<dc:identifier>ibc-148806</dc:identifier>
<dc:title xml:lang="es">Tumor miofibroblástico inflamatorio: causa excepcional de invaginación intestinal</dc:title>
<dc:subject>^d7604^s22012</dc:subject>
<dc:subject>^d24338^s22074</dc:subject>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d14307^s22012</dc:subject>
<dc:subject>^d7604^s22032</dc:subject>
<dc:subject>^d9573^s29166</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d29341^s22074</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24501^s22012</dc:subject>
<dc:subject>^d9128^s22022</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d9573^s22012</dc:subject>
<dc:subject>^d7991^s22045</dc:subject>
<dc:subject>^d4805^s22074</dc:subject>
<dc:subject>^d24501^s22027</dc:subject>
<dc:subject>^d7604^s29166</dc:subject>
<dc:type>article</dc:type>
<dc:date>201601</dc:date>
</metadata>
</record>
</ibecs-document>
